Safety study of JP-1366 with common heart and blood medications
Part of Heart & circulation clinical trials.
This trial tests how a new drug, JP-1366, interacts with several common heart and blood medications (clopidogrel, aspirin, atorvastatin, and apixaban) in healthy volunteers. It aims to see if the combination is safe and how the drugs affect each other in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 19 and 64 years old
- Weigh at least 50 kg (or 45 kg for women) and have a BMI between 18 and 30
- Be in good general health without significant medical conditions
- No history of bleeding disorders or gastrointestinal diseases/surgeries that could affect drug absorption
- No hereditary conditions like galactose intolerance or lactose deficiency
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called JP-1366 to see if it can prevent stomach ulcers caused by long-term NSAID use (like ibuprofen or naproxen) for conditions such as arthritis. It may be a good fit if you need to take NSAIDs for at least 24 weeks and have a higher risk of ulcers.
This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.
This early-stage study tests an investigational drug called JPI-547 in healthy male volunteers. The goal is to see how food and ethnic background affect how the drug moves through the body and to check that it is safe. If you qualify, you'll help doctors understand this drug before it is tested in patients.
This early-phase study tests a new drug in healthy volunteers to see how safe it is and how the body processes it. It helps doctors decide the right dose for future studies.
This is an early-stage safety study testing a new drug called JPH034 in healthy volunteers. Researchers want to see how the drug is tolerated and what happens to it in your body.
This trial tests how a new drug (JMKX003142) interacts with other substances in healthy volunteers. It helps researchers understand how the drug is absorbed and processed, which is a key step before it can be tested in patients.
Hear when a new Drug Drug Interaction (DDI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.